Osaic Holdings
GPCR icon

Osaic Holdings’s Structure Therapeutics GPCR Stock Holding History

Osaic Holdings’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Sell
44,416
-14,822
-25% -$1.01M ﹤0.01% 2015
2025
Q4 		$4.12M Sell
59,238
-3,601
-6% -$147K 0.01% 1503
2025
Q3 		$1.23M Sell
62,839
-523
-0.8% -$10.4K ﹤0.01% 2606
2025
Q2 		$1.31M Buy
63,362
+31,972
+102% +$703K ﹤0.01% 2271
2025
Q1 		$543K Buy
31,390
+598
+2% +$14.6K ﹤0.01% 2787
2024
Q4 		$835K Buy
30,792
+30,272
+5,822% +$1.07M ﹤0.01% 2343
2024
Q3 		$22.8K Buy
520
+22
+4% +$851 ﹤0.01% 5298
2024
Q2 		$19.6K Sell
498
-944
-65% -$38.8K ﹤0.01% 5363
2024
Q1 		$61.8K Buy
1,442
+231
+19% +$9.74K ﹤0.01% 4587
2023
Q4 		$49.3K Buy
1,211
+655
+118% +$37.5K ﹤0.01% 4919
2023
Q3 		$28K Buy
+556
New +$17.9K ﹤0.01% 5370

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Osaic Holdings's GPCR Position: Q1 2026 in Review

Osaic Holdings reduced its Structure Therapeutics (GPCR) stake by 25% in Q1 2026, selling an estimated $1.01M and leaving 44,416 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

Osaic Holdings first reported a position in GPCR in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.12M in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Osaic Holdings held 44,416 shares of Structure Therapeutics worth $2.14M as of Q1 2026.
  • Osaic Holdings sold 14,822 Structure Therapeutics shares in Q1 2026, an estimated $1.01M.
  • Structure Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2015 holding.
  • Osaic Holdings first reported a position in Structure Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Osaic Holdings's Structure Therapeutics position peaked at $4.12M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.